NCT06202456

A Phase IV Study of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver

A Single-arm, Multicenter Phase IV Study to Investigate the Efficacy and Safety of Huazhi Rougan Granule in the Treatment of Non-alcoholic Simple Fatty Liver (Damp-heat Obstruction Syndrome: Shi-Re-Zhong-Zu Zheng)

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 2,007 (actual)
• Sponsor: Shandong New Time Pharmaceutical Co., LTD · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

An open Label, Single-arm, Multicenter phase IV study; There was a 2-week screening period and a 12-week / 24-week treatment period

Conditions

• Efficacy and Safety

Interventions

Type	Name	Description
DRUG	Huazhi Rougan granule	Huazhi Rougan granule

Timeline

• Start date: 2020-05-13
• Primary completion: 2022-06-09
• Completion: 2022-06-09
• First posted: 2024-01-11
• Last updated: 2024-01-11

Locations

1 site across 1 country: China